Authors
Latest:
CMSC Live: 2024 Annual Meeting Day 3Host Jeffrey Wilken, PhD, chats with Marijean Buhse, PhD, RN, NP-C, MSCN; Amy Sullivan, PsyD, ABPP; and John DeLuca, PhD, ABPP, FACRM, FAPA, FAPS, FNAN, about the third day of the 2024 CMSC Annual Meeting in Nashville, Tennessee.
Latest:
Ian Maidment, PhD: Treating Sleep Problems in Those with DementiaThe senior lecturer in Clinical Pharmacy at Aston University talked about issues facing the medical community in treating those with dementia who have sleep problems.
Latest:
Looking to the Future of Stroke Care: Protection and RestorationInterest in advancing research in stroke therapeutics has historically come in fits and starts. Now with intravenous tPA and thrombectomy in regular use, experts are looking to get a step ahead of the damage.
Latest:
Exploring CB1, CB2 in Various Neurological ConditionsCannabinoids are being explored in a variety of conditions, ranging from Alzheimer disease to migraine.
Latest:
Recommendations for RRMS ManagementAhmed Zayed Obeidat MD, PhD; Ravi Dukkipati, MD; and Gabriel Pardo, MD, FAAN, share key takeaways for clinicians treating RRMS.
Latest:
Daphne Chylinski: Arousals During Sleep Are Strongly Linked to Alzheimer Disease PathophysiologyChylinski spoke about the relationship between the increased number of arousals during sleep and the pathogenesis of Alzheimer disease.
Latest:
Biofluid Biomarkers Hold Promise for the Future of Huntington DiseaseCurrently, there are no disease-modifying medications for Huntington disease and few interventions available to effectively alleviate symptoms, while the lack of indicators of pathobiological processes at the molecular level has limited the ability to prove efficacy and safety in clinical trials.
Latest:
Dennis Selkoe, MD: Current Challenges in Alzheimer Disease and Hope for the FutureSelkoe spoke to a number of topics in the Alzheimer space, including the challenges in the field and his excitement for the future.
Latest:
Alon Avidan, MD: Improving Narcolepsy ManagementThe director of the Sleep Disorders Center and vice-chair of the department of neurology at UCLA David Geffen School of Medicine detailed the greatest need in the management of narcolepsy
Latest:
Gilbert L'Italien, PhD: The Economic Impact of MIDAS Disability Grades in MigraineThe senior VP of Global Health Economics and Outcomes Research and Epidemiology at Biohaven Pharmaceuticals discussed the findings from a poster presentation on the economic impact of migraine disability at AHS 2020.
Latest:
Efficacy and Tolerability on Display by SRP-9003 Over 2 Years in LGMD2EOver a 2-year period, SRP-9003 elicited sustained protein expression in muscle tissue and stabilized North Star Assessment for Dysferlinopathies scores.
Latest:
Susan Hutchinson, MD: The Potential of the Gepant Class in Acute MigraineThe director of the Orange County Migraine and Headache Center spoke about the adherence issues in acute migraine treatment and how the safety profile of investigational medications such as rimegepant and ubrogepant suggests they may be able to address them.
Latest:
Neishay Ayub, MD: Stratifying SUDEP RiskThe Clinical Fellow in Neurophysiology and Epilepsy at Massachusetts General Hospital spoke about the implications of this assessment of SUDEP.
Latest:
The Approval of Fenfluramine for Treating Dravet SyndromeTwo experts explain the impact of the drug fenfluramine’s FDA approval in the treatment of Dravet syndrome.
Latest:
World Alzheimer Day 2019: Key Takeaways From Leaders in Alzheimer Disease and DementiaIn recognition of World Alzheimer Day, experts in Alzheimer disease and dementia share insight from the latest Alzheimer Disease International's yearly World Alzheimer Report.
Latest:
A Shortage of Headache Medicine Physicians: How Trainees Can Get InvolvedOur patients have a huge need for access to specialists, yet unfortunately, there is a huge shortage of headache specialists.
Latest:
Huma Sheikh, MD: Complementary Approaches for Multimodal Migraine TreatmentThe assistant professor of neurology at Mount Sinai Health System spoke about the recent trend toward approaching migraine in a more holistic fashion, and the incorporation of nonpharmacologic options for patients with the chronic headache condition.
Latest:
Nancy Chiaravalloti, PhD: Using Cognitive Rehab Tactics in Healthy IndividualsThe director of Centers for Neuropsychology and Neuroscience Research, and Traumatic Brain Injury Research at Kessler Foundation discussed the use of cognitive rehabilitation techniques in healthy individuals.
Latest:
EEG Abnormalities in Acutely Ill Patients With COVID-19Preliminary findings from a retrospective sample series in the Bronx, New York.
Latest:
Stephen Hantus, MD: Acute Symptomatic SeizuresThe Director of the cEEG and Epilepsy Consult Service at the Cleveland Clinic Epilepsy Center spoke about the cautious for physicians treating patients with acute symptomatic seizures.
Latest:
Recent Advances in Movement Disorders: Fernando Pagan, MDThe course director of ATMRD 2023 provided perspective on the notable strides made in the movement disorder field, including the significant progress made in drug delivery. [WATCH TIME: 5 minutes]
Latest:
Stephen Silberstein, MD: Treating Medication Overuse HeadacheThe director of the Jefferson Headache Center at Jefferson University Hospital discussed the need for physicians to revisit how they treat patients with chronic migraine who have developed medication overuse headache.
Latest:
COVID-19 Neurological Complications More Likely in Those with Hypertension, DiabetesTwo-thirds of patients with critical results were African American, demonstrating an additional need to explore associations between ethnicity and COVID-19.
Latest:
Geert Mayer, MD: Safety, Efficacy of Solriamfetol for Excessive Sleepiness In Narcolepsy, OSALong-term maintenance of efficacy was demonstrated with solriamfetol for treatment of excessive sleepiness with narcolepsy or obstructive sleep apnea.
Latest:
Anton P. Porsteinsson, MD: Addressing Trial Design and Symptom Intervention in Alzheimer DiseaseThe director of the University of Rochester Alzheimer's Disease Care, Research and Education Program spoke about the need to rethink trial design and Alzheimer neuropsychiatric symptom management.
Latest:
Recognizing Symptoms and Causes of Rapidly Progressive Dementia: Gregory Day, MD, MSc, MSCI, FAANThe neurologist at Mayo Clinic in Jacksonville Florida provided perspective on his talk given at the 2023 AAN annual meeting on rapidly progressive dementia. [WATCH TIME: 6 minutes]
Latest:
David Irwin, MD: Differentiating Dementias in Living PatientsThe assistant professor and cognitive neurologist at the University of Pennsylvania Frontotemporal Degeneration Center will share additional insights on Alzheimer disease at the upcoming International Congress on the Future of Neurology, taking place September 27-28, 2019 in New York City.
